Amo Pharma Limited
09431909
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
- Going concern doubt noted in accounts (-10)
- 3 outstanding charges (-6)
Details
Compliance
Last accounts
31/12/2024
total exemption full
Next accounts due
30/09/2026
Confirmation statement
Last: 10/02/2026
Due 24/02/2027
Industry
Officers
director · Since 10/02/2015
CHIEF SCIENTIFIC OFFICER
BRITISH · ENGLAND · Age 63
Also on 1 other board
director · Since 16/08/2021
BIOPHARMACEUTICAL EXECUTIVE
AMERICAN · UNITED STATES · Age 72
Persons with Significant Control
Mr Dermot Desmond
Irish · Switzerland · Age 75
Iiu, C/O Legal Counsel, 5th Floor, Ifsc House, Custom House Quay, Dublin 1, D01 R2P9
Notified 04/02/2020
Former PSCs
Woodford Patient Capital Trust Plc
Ceased 08/01/2020
Iiu Nominees Limited
Ceased 04/02/2020
Charges3 outstanding
IIU NOMINEES LIMITED
IIU NOMINEES LIMITED
IIU NOMINEES LIMITED
CompanyRankvs 4657+ SIC 72190 peers21
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
as at the date of approval of these financial statements. This creates a material uncertainty that may cast significant doubt on the company's ability to continue as a going concern, for a period of at least 12 months from the date of approval of these financial statements and, therefore, they may be unable to realise their assets and discharge their liabilities in the normal co
Key FinancialsYear ending 31/12/2024
Net Worth
-£44.1M
Balance sheet strength
Cash
£155k
Cash in the bank
Net Current Assets
-£44.1M
Working capital
Current Assets
£2.7M
Current Liabilities
£46.8M
Fixed Assets
£2k
Debtors
£2.5M
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 0.06 |
Derived from filed accounts. Not audited figures.